Medical resource use in a phase III trial (SO 14796) of XelodaTM (capecitabine) in previously untreated advanced/metastatic colorectal cancer
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S68-S69
- https://doi.org/10.1016/s0959-8049(99)80640-6